Telehealth Education for Vaccine Hesitancy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how telehealth education influences people's willingness to adopt preventive health strategies, such as improved nutrition and managing conditions like high blood pressure and diabetes. Participants will receive either personalized education tailored to their health risks or general wellness education through telehealth. The researchers aim to determine if personalized advice increases adherence to preventive health measures. The trial seeks individuals working or training in fields like healthcare, education, or food services, who are comfortable using telehealth technology like tablets or smartphones. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance preventive health strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on education about vaccines and wellness, so it's unlikely that you would need to change your medication routine.
What prior data suggests that this telehealth education program is safe?
Research shows that telehealth education programs are generally safe and easy to manage. In the Telehealth: Wellness and Vaccination approach, one study found that virtual education for healthcare providers improved their knowledge and reduced vaccine hesitancy, with no reported negative effects. This suggests participants likely respond well to this type of education.
The TeleHealth: Wellness Only approach also uses telehealth for education. Studies have shown that telemedicine, including telehealth, helps people make health-related decisions like getting vaccinated without causing harm.
Since these programs focus on education and do not involve new medications or treatments, they are considered low-risk. Participants usually feel more informed and confident, with no significant negative effects.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how telehealth can tackle vaccine hesitancy by focusing on personalized education and preventative health strategies. Unlike traditional methods that might involve in-person consultations, these telehealth interventions offer convenience and accessibility, allowing individuals to receive tailored advice on nutrition, work-life balance, and disease prevention from the comfort of their homes. The trial also investigates whether personalized strategies focusing on individual health risks can engage patients more effectively than standard educational approaches. This could lead to more informed health decisions and improved vaccination rates.
What evidence suggests that this trial's telehealth education treatments could be effective for vaccine hesitancy?
Research has shown that telehealth education can help reduce worries about vaccines. For example, programs educating pregnant women about COVID-19 vaccines have increased their willingness to get vaccinated. Additionally, online education for healthcare workers has improved their understanding and reduced their concerns about vaccines. This trial will compare two telehealth approaches: one arm will focus on personalized preventative medicine strategies, while the other will provide standardized preventative medicine education. Both arms aim to inform participants and potentially change their views on vaccines. Although more research is needed, early results are promising for using telehealth to support health and prevention efforts.12467
Who Is on the Research Team?
Sara Al-Dahir, PhD
Principal Investigator
Xavier University of Louisiana.
Klaus Heyer, PhD
Principal Investigator
Nunez Community College
Are You a Good Fit for This Trial?
This trial is for adults aged 18-55 working in high-risk industries like healthcare, education, and food service. Participants should have incomplete COVID-19 or flu vaccinations, speak English, and be able to use telehealth tech. Those with severe allergies to vaccines, certain heart conditions, immunosuppressive diseases, or who've completed their COVID-19 vaccine series can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive telehealth interventions focusing on wellness, with one arm also receiving vaccination education and counseling
Follow-up
Participants are monitored for vaccine completion and changes in vaccine hesitancy
What Are the Treatments Tested in This Trial?
Interventions
- Telehealth: Wellness and Vaccination
- TeleHealth: Wellness Only
Find a Clinic Near You
Who Is Running the Clinical Trial?
Xavier University of Louisiana.
Lead Sponsor